Advertisement
Research Article

The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors

  • Iñigo Landa equal contributor,

    equal contributor Contributed equally to this work with: Iñigo Landa, Sergio Ruiz-Llorente

    Affiliation: Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

    X
  • Sergio Ruiz-Llorente equal contributor,

    equal contributor Contributed equally to this work with: Iñigo Landa, Sergio Ruiz-Llorente

    Affiliation: Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC), Autonomous University of Madrid (CSIC-UAM), Madrid, Spain

    X
  • Cristina Montero-Conde,

    Affiliations: Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC), Autonomous University of Madrid (CSIC-UAM), Madrid, Spain

    X
  • Lucía Inglada-Pérez,

    Affiliations: Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, ISCIII Centre for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain

    X
  • Francesca Schiavi,

    Affiliation: Familial Cancer Clinic, Veneto Institute of Oncology IRCCS, Padova, Italy

    X
  • Susanna Leskelä,

    Affiliation: Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

    X
  • Guillermo Pita,

    Affiliation: Genotyping Unit-CEGEN, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

    X
  • Roger Milne,

    Affiliation: Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

    X
  • Javier Maravall,

    Affiliation: Hospital Universitario Arnau de Vilanova-IRB Lleida, Lleida, Spain

    X
  • Ignacio Ramos,

    Affiliation: Hospital de Requena, Valencia, Spain

    X
  • Víctor Andía,

    Affiliation: Hospital General Universitario Gregorio Marañón, Madrid, Spain

    X
  • Paloma Rodríguez-Poyo,

    Affiliation: Hospital General Universitario Gregorio Marañón, Madrid, Spain

    X
  • Antonino Jara-Albarrán,

    Affiliation: Hospital General Universitario Gregorio Marañón, Madrid, Spain

    X
  • Amparo Meoro,

    Affiliation: Hospital Universitario Reina Sofía, Murcia, Spain

    X
  • Cristina del Peso,

    Affiliation: Hospital Universitario Reina Sofía, Murcia, Spain

    X
  • Luis Arribas,

    Affiliation: Hospital Marina Alta, Denia, Spain

    X
  • Pedro Iglesias,

    Affiliation: Hospital General de Segovia, Segovia, Spain

    X
  • Javier Caballero,

    Affiliation: Hospital Reina Sofía, Córdoba, Spain

    X
  • Joaquín Serrano,

    Affiliation: Hospital General Universitario de Alicante, Alicante, Spain

    X
  • Antonio Picó,

    Affiliation: Hospital General Universitario de Alicante, Alicante, Spain

    X
  • Francisco Pomares,

    Affiliation: Hospital Universitario San Juan de Alicante, Alicante, Spain

    X
  • Gabriel Giménez,

    Affiliation: Hospital de Sabadell-Parc Taulí, Sabadell, Spain

    X
  • Pedro López-Mondéjar,

    Affiliation: Hospital General Universitario de Elche, Elche, Spain

    X
  • Roberto Castello,

    Affiliation: Civil Hospital, Verona, Italy

    X
  • Isabella Merante-Boschin,

    Affiliation: Surgical Pathology, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy

    X
  • Maria-Rosa Pelizzo,

    Affiliation: Surgical Pathology, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy

    X
  • Didac Mauricio,

    Affiliation: Hospital Universitario Arnau de Vilanova-IRB Lleida, Lleida, Spain

    X
  • Giuseppe Opocher,

    Affiliations: Familial Cancer Clinic, Veneto Institute of Oncology IRCCS, Padova, Italy, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy

    X
  • Cristina Rodríguez-Antona,

    Affiliations: Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, ISCIII Centre for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain

    X
  • Anna González-Neira,

    Affiliation: Genotyping Unit-CEGEN, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

    X
  • Xavier Matías-Guiu,

    Affiliation: Hospital Universitario Arnau de Vilanova-IRB Lleida, Lleida, Spain

    X
  • Pilar Santisteban mail,

    psantisteban@iib.uam.es (PS); mrobledo@cnio.es (MR)

    Affiliation: Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC), Autonomous University of Madrid (CSIC-UAM), Madrid, Spain

    X
  • Mercedes Robledo mail

    psantisteban@iib.uam.es (PS); mrobledo@cnio.es (MR)

    Affiliations: Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, ISCIII Centre for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain

    X
  • Published: September 04, 2009
  • DOI: 10.1371/journal.pgen.1000637

Reader Comments (0)

Post a new comment on this article